1-15 of 66
Redefining Durability in Wet AMD: Insights from the SOL‑1 Superiority Trial
Medical Industry FeatureRedefining Durability in Wet AMD: Insights from the SOL‑1 Superiority Trial
Priya Vakharia, MD
Andrew Moshfeghi
Ocular Management in PROC: Insights on Collaborative Care Across Practice Settings
Project Oncology®Ocular Management in PROC: Insights on Collaborative Care Across Practice Settings
Jennifer Caudle, DO, FACOFP
Ida Micaily, MD
Jeffrey Varanelli, OD
Faricimab vs. Aflibercept for Retinal Vein Occlusion
Eye on Ocular HealthFaricimab vs. Aflibercept for Retinal Vein Occlusion
Michael Javaheri, MD, MSc, FASRS
Managing RVO: Goals of Early Intervention
Eye on Ocular HealthManaging RVO: Goals of Early Intervention
Michael Javaheri, MD, MSc, FASRS
Choosing the Right Therapy for RVO Patients
Eye on Ocular HealthChoosing the Right Therapy for RVO Patients
Michael Javaheri, MD, MSc, FASRS
The Missed Diagnosis: A 45-Year-Old Software Engineer Who Complains of Dry Eyes
MinuteCE®The Missed Diagnosis: A 45-Year-Old Software Engineer Who Complains of Dry Eyes
Douglas K. Devries, OD
Cecelia Koetting, OD, FAAO
- advertisement
Douglas K. Devries, OD
Cecelia Koetting, OD, FAAO
The Neverending Journey: A 66-Year-Old Patient Who Has Undergone Several Rounds of Tea Tree Oil–Based Treatment
MinuteCE®The Neverending Journey: A 66-Year-Old Patient Who Has Undergone Several Rounds of Tea Tree Oil–Based Treatment
Douglas K. Devries, OD
Cecelia Koetting, OD, FAAO
Douglas K. Devries, OD
Cecelia Koetting, OD, FAAO
Moving Beyond Lid Hygiene: Evidence-Based Treatment Strategies
MinuteCE®Moving Beyond Lid Hygiene: Evidence-Based Treatment Strategies
Douglas K. Devries, OD
Cecelia Koetting, OD, FAAO
Douglas K. Devries, OD
Cecelia Koetting, OD, FAAO
At the Intersection of DB, DED, MGD, and Other Forms of Blepharitis
MinuteCE®At the Intersection of DB, DED, MGD, and Other Forms of Blepharitis
Douglas K. Devries, OD
Cecelia Koetting, OD, FAAO
- advertisement
Return and Revisit: A 38-Year-Old Patient Returns for Follow-up After Lotilaner Treatment
MinuteCE®Return and Revisit: A 38-Year-Old Patient Returns for Follow-up After Lotilaner Treatment
Douglas K. Devries, OD
Cecelia Koetting, OD, FAAO
Closing the Loop: Structured Follow-Up and Patient Communication
MinuteCE®Closing the Loop: Structured Follow-Up and Patient Communication
Douglas K. Devries, OD
Cecelia Koetting, OD, FAAO
Hidden in Plain Sight: A Modern Guide to Detecting and Managing Early Neurotrophic Keratitis
CME/CEHidden in Plain Sight: A Modern Guide to Detecting and Managing Early Neurotrophic Keratitis
Cecelia Koetting, OD, FAAO
Lisa Hornick, OD, MBA, FAAO
Katherine Rachon, OD, FAAO
